Anda Biopharma
PrivateLast Round
Series A
Mar 1, 2025
Company Overview
Anda Biopharma is a biotechnology company that develops personalized cancer therapies and vaccines focused on tumor neoantigens using an AI-driven analysis platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anda Biopharma Comparables
Compare Anda Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Neoantigen Therapeutics Co., Ltd. | 89% | |
| Likang Life Sciences | 88% | |
| WestGene Biopharma | 79% | |
Anda Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2025 |
Anda Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 北京首业君立投资管理有限公司 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2025
Led by Beijing Shouye Junli Investment Management
Anda Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anda Biopharma's valuation, stock price, and market status.